Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma

Hashikawa,Keiko; Yasumoto,Shinichiro; Nakashima,Kazutaka; Arakawa,Fumiko; Kiyasu,Junichi; Kimura,Yoshizo; Saruta,Hiroshi; Nakama,Takekuni; Yasuda,Kaori; Tashiro,Kosuke; Kuhara,Satoru; Hashimoto,Takashi; Ohshima,Koichi

doi:10.3892/ijo.2014.2524

Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma

Authors:
- Keiko Hashikawa
- Shinichiro Yasumoto
- Kazutaka Nakashima
- Fumiko Arakawa
- Junichi Kiyasu
- Yoshizo Kimura
- Hiroshi Saruta
- Takekuni Nakama
- Kaori Yasuda
- Kosuke Tashiro
- Satoru Kuhara
- Takashi Hashimoto
- Koichi Ohshima
View Affiliations

Affiliations: Department of Dermatology, Kurume University School of Medicine, Japan, Department of Pathology, Kurume University School of Medicine, Japan, Cell Innovator, Inc., Venture Business Laboratory of Kyushu University, Japan, Laboratory of Molecular Gene Technics, Department of Genetic Resources Technology, Graduate School of Genetic Resources Technology, Faculty of Agriculture, Kyushu University, Japan
Published online on: June 26, 2014 https://doi.org/10.3892/ijo.2014.2524
Pages: 1200-1208

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The characteristic histopathological feature of mycosis fungoides (MF) and adult T-cell leukemia/lymphoma (ATLL) is epidermotropism. To identify the mechanism for epidermotropism of lymphoma cells, total RNAs were obtained from skin biopsies of epidermis and dermis of MF and ATLL patients by means of laser capture microdissection, and used for subsequent complementary DNA (cDNA) microarray experiments. This procedure has made it possible for us to observe and evaluate the regional environment of MF and ATLL. Hierarchical cluster analysis revealed that the cDNAs could be clearly differentiated into MF and ATLL. CCL27 was expressed in the dermis generated from keratinocytes, CCR4/CCR6/CCR7/CCR10/cutaneous lymphocyte-associated antigen (CLA) lymphoma cells in the dermis, and CCL21 in the extracellular matrix (stroma). Lymphotoxin (LT) β and CCL21 expression was significantly higher and that of CCR10 relatively for MF, while CCR4 and CLA expression was relatively higher for ATLL. In the epithelium, keratinocytes expressed CCL20/CCL27, and lymphoma cells CCR4/CCR6/CCR10, while CCR4, CCR6, CCL20 and CCL27 expression was relatively higher for ATLL than MF. The dermis of MF, but not that of ATLL, showed correlation between CCR7 and CCL21. These findings support the suggestion that chemokines and chemokine receptors are involved in the pathogenesis of MF and ATLL, indicate that cutaneous homing seems to be different for MF and ATLL, and point to the possibility that cutaneous T-cell lymphomas originate in regulatory T cells, especially in the case of ATLL.

View Figures

View References

1	Willemze R, Jaffe ES, Burg G, et al: WHO-EORTC classification for cutaneous lymphomas. Blood. 105:3768–3785. 2009. View Article : Google Scholar
2	Kikuchi A, Ohata Y, Matsumoto H, Sugiura M and Nishikawa T: Anti-HTLV-1 antibody positive cutaneous T-cell lymphoma. Cancer. 79:269–274. 1997. View Article : Google Scholar : PubMed/NCBI
3	Notohamiprodjo M, Segerer S, Huss R, et al: CCR10 is expressed in cutaneous T-cell lymphoma. Int J Cancer. 115:641–647. 2005. View Article : Google Scholar : PubMed/NCBI
4	Picker LJ, Terstappen LW, Rott LS, Streeter PR, Stein H and Butcher EC: Differential expression of homing-associated adhesion molecules by T-cell subsets in man. J Immunol. 145:3247–3255. 1990.PubMed/NCBI
5	Picker LJ, Michie SA, Rott LS and Butcher EC: A unique phenotype of skin-associated lymphocytes in humans: preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol. 136:1053–1068. 1990.PubMed/NCBI
6	Berg EL, Yoshino T, Rott LS, et al: The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell leukocyte adhesion molecule 1. J Exp Med. 174:1461–1466. 1991. View Article : Google Scholar : PubMed/NCBI
7	Tanaka Y, Wake A, Horgan KJ, et al: Distinct phenotype of leukemic T cells with various tissues tropisms. J Immunol. 158:3822–3829. 1997.PubMed/NCBI
8	Rubin MA: Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer. J Pathol. 195:80–86. 2001. View Article : Google Scholar : PubMed/NCBI
9	Lin SM, Du P, Huber W and Kibbe WA: Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 36:e112008. View Article : Google Scholar : PubMed/NCBI
10	Du P, Kibbe WA and Lin SM: lumi: a pipeline for processing Illumina microarray. Bioinformatics. 24:1547–1548. 2008. View Article : Google Scholar : PubMed/NCBI
11	Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 98:5116–5121. 2001. View Article : Google Scholar : PubMed/NCBI
12	Ohshima K, Kawasaki C, Muta H, et al: CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology. 39:156–162. 2001. View Article : Google Scholar : PubMed/NCBI
13	Gambichler T, Skrygan M, Appelhans C, et al: Expression of human beta-defensins in patients with mycosis fungoides. Arch Dermatol Res. 299:221–224. 2007. View Article : Google Scholar : PubMed/NCBI
14	Browning JL, Dougas I, Ngam-ek A, et al: Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J Immunol. 154:33–46. 1995.PubMed/NCBI
15	Ware CF, Crowe PD, Grayson MH, Androlewicz MJ and Browning JL: Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol. 149:3881–3888. 1992.PubMed/NCBI
16	Fu YX, Huang G, Wang Y and Chaplin DD: B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med. 187:1009–1018. 1998. View Article : Google Scholar : PubMed/NCBI
17	Ware CF: Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol. 23:787–819. 2005. View Article : Google Scholar : PubMed/NCBI
18	Rennert PD, Browning JL, Mebius R, Mackay F and Hochman PS: Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med. 184:1999–2006. 1996. View Article : Google Scholar : PubMed/NCBI
19	Tumanov AV, Kuprash DV and Nedospasov SA: The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev. 14:275–288. 2003. View Article : Google Scholar : PubMed/NCBI
20	Dejardin E, Droin NM, Delhase M, et al: The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 17:525–535. 2002. View Article : Google Scholar : PubMed/NCBI
21	Dejardin E: The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol. 72:1161–1179. 2006. View Article : Google Scholar : PubMed/NCBI
22	Matsushima A, Kaisho T, Rennert PD, et al: Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J Exp Med. 193:631–636. 2001. View Article : Google Scholar
23	Hehlgans T, Stoelcker B, Stopfer P, et al: Lymphotoxin-beta receptor immune interaction promotes tumor growth by inducing angiogenesis. Cancer Res. 62:4034–4040. 2002.PubMed/NCBI
24	Barkett M and Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 18:6910–6924. 1999. View Article : Google Scholar : PubMed/NCBI
25	Biswas DK, Martin KJ, McAlister C, et al: Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res. 63:290–295. 2003.PubMed/NCBI
26	Dhawan P, Su Y, Thu YM, et al: The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J Biol Chem. 283:15399–15408. 2008. View Article : Google Scholar : PubMed/NCBI
27	Haybaeck J, Zeller N, Wolf MJ, et al: A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell. 16:295–308. 2009. View Article : Google Scholar : PubMed/NCBI
28	Gilmore TD: Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene. 18:6925–6937. 1999. View Article : Google Scholar : PubMed/NCBI
29	Häcker H and Karin M: Is NF-kappaB2/p100 a direct activator of programmed cell death? Cancer Cell. 2:431–433. 2002.PubMed/NCBI
30	Martinez-Delgado B, Meléndez B, Cuadros M, et al: Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res. 10:4971–4982. 2004. View Article : Google Scholar
31	Martinez-Delgado B, Cuadros M, Honrado E, et al: Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia. 19:2254–2263. 2005. View Article : Google Scholar : PubMed/NCBI
32	Ballester B, Ramuz O, Gisselbrecht C, et al: Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene. 25:1560–1570. 2006. View Article : Google Scholar : PubMed/NCBI
33	Bekiaris V, Gaspal F, Kim MY, et al: CD30 is required for CCL21 expression and CD4 T cell recruitment in the absence of lymphotoxin signals. J Immunol. 182:4771–4775. 2009. View Article : Google Scholar : PubMed/NCBI
34	Kallinich T, Muche JM, Qin S, Sterry W, Audring H and Kroczek RA: Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol. 121:1045–1052. 2003. View Article : Google Scholar : PubMed/NCBI
35	Sokolowska-Wojdylo M, Wenzel J, Gaffal E, et al: Circulating clonal CLA(+) and CD4(+) T cells in Se’zary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol. 152:258–264. 2005.PubMed/NCBI
36	Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 90:354–371. 1997.
37	Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001.PubMed/NCBI
38	von Andrian UH and Mempel TR: Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 3:867–878. 2003.PubMed/NCBI
39	Balkwill F: Cancer and the chemokine network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
40	Jones D, O’Hara C, Kraus MD, et al: Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 96:685–690. 2000.PubMed/NCBI
41	Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS and Kupper TS: Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol. 119:1405–1410. 2002. View Article : Google Scholar : PubMed/NCBI
42	Narducci MG, Scala E, Bresin A, et al: Skin homing of Se’zary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood. 107:1108–1115. 2006.
43	Tang HL and Cyster JG: Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science. 284:819–822. 1999. View Article : Google Scholar : PubMed/NCBI
44	Wu M, Fang H and Hwang ST: Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells. J Immunol. 167:4791–4795. 2001. View Article : Google Scholar : PubMed/NCBI
45	Edelson RL: Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann N Y Acad Sci. 941:1–11. 2001. View Article : Google Scholar : PubMed/NCBI
46	Homey B, Alenius H, Müller A, et al: CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med. 8:157–165. 2002. View Article : Google Scholar : PubMed/NCBI
47	Fujita Y, Abe R, Sasaki M, et al: Presence of circulating CCR10⁺ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides. Clin Cancer Res. 12:2670–2675. 2006.PubMed/NCBI
48	Kagami S, Sugaya M, Minatani Y, et al: Elevated serum CTACK/CCL27 levels in CTCL. J Invest Dermatol. 126:1189–1191. 2006. View Article : Google Scholar : PubMed/NCBI
49	Berger CL, Tigelaar R, Cohen J, et al: Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood. 105:1640–1647. 2005. View Article : Google Scholar : PubMed/NCBI
50	Karube K, Aoki R, Sugita Y, et al: The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma. Mod Pathol. 21:617–625. 2008. View Article : Google Scholar : PubMed/NCBI